FSD Pharma Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HUGE research report →
Price Chart
About the company
FSD Pharma Inc. is a biopharmaceutical research and development company, operating through its various subsidiaries. The firm's leading drug candidate, FSD-201, is currently undergoing Phase II clinical trials for the treatment of COVID-19 disease.
- CEO
- Zeeshan Saeed
- IPO
- 2018
- Employees
- 17
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on HUGE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $66.67K
- P/E
- -0.15
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.26
- EV/EBITDA
- 0.14
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -108.36%
- ROIC
- -192.35%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-2,552,278+41.4%
- Op Income
- $-19,929,008
- Net Income
- $-18,564,915+20.4%
- EPS
- $-0.47+21.7%
- OCF Growth
- +61.1%
- FCF Growth
- +61.6%
- 52W High
- $109.19
- 52W Low
- $0.09
- 50D MA
- $8.13
- 200D MA
- $36.69
- Beta
- 0.85
- RSI (14)
- 39
- Avg Volume
- 196.16K
No earnings-call transcripts are available for HUGE yet.
- Free Float
- 81.0%
- Shares Outstanding
- 741.61K
- Float Shares
- 600.70K
of shares held by institutions
18 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Resource Management, LLC | 13.74K | 0 |
Our HUGE coverage
Recent articles, reports, and earnings notes.
No research on HUGE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HUGE report →Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders
newsfilecorp.com · Jul 23
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates
accessnewswire.com · Jan 17
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation
accesswire.com · Nov 25
FSD Pharma Announces Share Consolidation and Name Change
newsfilecorp.com · Aug 9
FSD Pharma Is Up 216% Today. What Is Going On With HUGE Stock?
investorplace.com · Aug 9
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team
accesswire.com · Aug 9
24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma
newsfilecorp.com · Jul 25
FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
newsfilecorp.com · Jul 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.